|
Mr. John Mohr is Senior Vice President of Business Development. He has over 20 years of industry experience in the life-science area. Previously, he held senior executive positions in corporate development with several bio-pharma companies including Topigen, Atherogenics and Perrigo. He was former Head of US Operations for Fournier Pharma responsible for US commercial and development activities, including the successful partnering and introduction of TriCor�, a billion dollar cardiovascular agent. Prior experience includes executive management positions at Merck. including worldwide responsibility for marketing for Pepcid�. Mr. Mohr has substantial experience in managing and licensing bio-pharma technologies as both operating executive and commercial strategist. He currently serves as a member of the Business Development Roundtable for the Biotechnology Council of New Jersey and a member of the Licensing Executive Society. | 